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Tumor necrosis factor (TNF-a), a I7 kDa cytokine, is a product of activated macrophages which was recently shown to be produced by rat and 
bovine Igranulosa cells. In the present work, human granulosa cells derived from preovulatory follicles were used, It was demonstrated that human 
granulosa cells produce. TNF-u (510 units/300000 cells per 15 h). This production was increased by addition of follicle-stimulating hormone or 
by a combination of human chorionic gonadotrophin and CSF to the culture media. TNF was also found in bovine follicular fluid and the concen- 
tration was higher in the periovulatory than mid-cycle follicles. TNF-a was found to increase prostaglandin F-2a production by human granulosa 
cells (P< 0.001). We conclude that granulosa cells are both a source and target organ for TNF-a. 
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1. INTRODUCTION 
Tumor necrosis factor- (TNF), a 17 kDa cytokine, 
is a product of stimulated monocytes and macrophages 
and also produced by lymphocytes, endothelial cells 
and keratinocytes. Most reports on TNF have dealt 
with its inflammatory and anti-tumor effects [l]. 
Recently, rat and bovine granulosa cells have been 
reported to produce TNF ]2,3]. Other studies have in- 
dicated a role for TNF in steroido~enesis in that it in- 
hibits follicle-stimulating hormone (FSH) or tumor 
growth factor-,& induced aromatase activity and induc- 
tion of progesterone synthesis by rat ovarian tissues 
[4,5]. The present study was conducted to determine (a) 
if human granulosa cells (GC) produce TNF; (b) if TNF 
production by follicular cells is regulated by 
gonadotropins; (c) the role of TNF in pre-ovulatory GC 
synthesis of prostanoids and progesterone; and (d) the 
level of TNF in follicular fluid during the cycle using 
bovine follicles. 
serum-free media were used for incubations. The cultures were in- 
cubated overnight with or without the following compounds (dose us- 
ed; range tested): FSH (25 ng/ml; 0.25-250 ng/ml; Metrodin, Teva). 
prostaglandin F-2o (PGF-ti; 10gM; l-300,&; Upjohn), colony 
stimulating factor-l (CSF crude preparation of L929 supernatant; 
20010; 5-50%), human chorionic gonadotrophin (hCG;B; 10 ng/ml; 
5-100 ng; spec. act. 12000 Wmg; NIH), TNF (0.3-3000 pM; 
rbTNF; Genzyne) or 8-bromoadenosine 3 ’ ,5 ’ -cyclic monophosphate 
(Ibr-CAMP; 3 mM; l-5 mM; Sigma). Aliquots of media were taken 
for analysis for TNI?, progesterone and PGF&. The TNF cytotox- 
icity was quantitated using 9 mm microwells at 4 x 104 L929 mice 
fibrosarcoma cells/well. Test samples were applied to the cells in 
serial dilutions in the presence of 50 fig/ml cycloheximide. After 12 h 
cell killing was quantitated by measuring the uptake of neutral red. 
One unit was defined as the concentration at which 50% of the cells 
were killed. Since TNF-b (lymphotoxin) can cause the same cytotoxic 
effect, each positive sample was neutralized by coincubation for 3 h 
at 4°C with monoclonal anti-human TNF-cu. 
2. MATERIALS AND METHODS 
GC were obtained from follicles stimulated by human menopausal 
gonadotropin and aspirated during vaginal ultrasound oocyte 
retrieval for IVF treatment. The treatment protocol for follicular 
recruitment and separation of GC using Ficoll gradients was done as 
described previously [a]. Microscopic examination of the preparation 
showed that 98% of the cells present were granulosa. 300000 cells per 
well containing 1 ml of Dulbecco’s modified Eagle medium sup- 
plemented with nutrient mixture F-12 Ham (1: 1 mixture; Sigma) 
The human monocyte preparation was prepared by modification 
of the method of Aderka et al. [7]. Briefly, white blood cells were 
separated from whole blood obtained from healthy donors on a 
Ficoll-Hypaque cushion (Pharmacia, Sweden). The monocytes were 
isolated by incubating the resultant ‘buffy coat’ at 37°C for 1 h in 
tissue culture plates, followed by washing with phosphate buffer 
solution to remove non-adherent cells. The adherent cells 
(monocles) were detached by versene and mechanically removed. 
After the cells were washed twice with phosphate buffer solution and 
media, the cells were treated the same as the granulosa cell 
preparations. 
Follicular fluid was obtained from periovulatory and mid-cycle 
follicles as described by Shemesh [S]. 
Progesterone and prostaglandin F-2o were measured by radioim- 
munoassay as described previously [8,9]. 
The Student t-test was performed for all data comparisons. Data 
are presented as means f SE. 
3. RESULTS 
Correspondence address: M. Shemesh, Kimron Veterinary Institute, 
POB 12, Bet Dagan, 50200 Israel 
Data presented in fig.1 demonstrate that human 
cultured GC secreted TNF (5-10 units/3 x lo5 cells per 
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Fig.1. TNF-a production by cultured GC. 300000 cells were 
incubated for 15 h with FSH (25 ng/ml), hCG (25 ng/ml) or CSF,, 
alone or in combination. Bars represent the mean zt SE of 5 
experiments of 5 replicates each. 
15 h incubation) as determined by bioassay and verified 
by specific neutralization by a monoclonal antibody to 
TNF-cu. 
To determine the role of the tropic hormones on 
TNF production, GC were incubated in the presence of 
FSH, hCG, crude CSF preparation, PGF-2a, and 8br- 
CAMP, alone or in combination. As can be seen in 
fig.1, FSH induced a significant enhancement (P < 
0.001) in TNF production over the control. In contrast, 
this stimulatory effect was not apparent in the presence 
of hCG, PGF-~JX, CSF or Sbr-CAMP. However, the 
combination of the crude CSF preparation and hCG in- 
duced a significant elevation (P < 0.001) in TNF pro- 
duction by the cultured GC. When isolated human 
monocytes were similarly incubated, FSH had no effect 
on TNF production. 
We next examined the effect of TNF on prostanoid 
production. As can be seen in fig.2, TNF (300 PM) in- 
duced a 3.4-fold increase in PGF-2cu production by 
cultured GC. However in the presence of FSH, this ef- 
fect was not apparent. FSH alone was found to 
Control FSH TNF TN F+FSH 
Fig.2. PGF-2cY production by cultured human GC. 300000 cells were 
incubated in tissue culture media for 15 h and the effect of addition 
of FSH (25 ng/ml) or TNF-(U (300 PM), alone or in combination, was 
measured. Bars represent the mean k SE of 5 experiments of 5 
replicates each. 
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Fig.3. Dose-response curve of progesterone and PGF-2ru production 
by human GC for TNF-cr. 300000 cells were incubated for 15 h in the 
presence of 0.3-3000 pM TNF-(Y and progesterone (solid lines) and 
PGF& (dotted lines) production was measured. Points represent the 
mean + SE of five experiments, each of 5 replicates. 
significantly (P < 0.001) inhibit PGF-k production by 
the cultured GC. 
To determine the possible role of TNF in 
steroidogenesis, progesterone production by the 
cultured GC was assayed. In the presence of TNF 
(fig.3) there was significant elevation in progesterone 
production (P < 0.05). However, the increase in pro- 
gesterone production by TNF was of the same 
magnitude as that induced by PGF-k alone (data not 
shown). The stimulation of both PGF-2cu and pro- 
gesterone production by TNF appears to be biphasic as 
the highest dose used (3000 PM) was inhibitory. 
DAYS OF ESTROUS CYCLE 
Fig.4. Concentration of TNF in bovine follicular fluid derived from 
early mid-cycle and periovulatory follicles (mean + SE). 
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In order to determine the extent of TNF production 
throughout the cycle, bovine follicular fluid was used. 
As can be seen in fig.4, measurable amounts of TNF 
were found in follicular fluid from mid-cycle ovaries 
(8-12 days). The activity in the periovulatory follicle 
was significantly higher (P < 0.05) than that in the mid- 
cycle ovaries. The activity was still high in fluid remain- 
ing in the follicular cavity in the 24 h after ovulation 
(corpora hemorrhagica present). 
4. DISCUSSION 
Data presented indicate that human GC produce 
TNF and that this production is regulated by FSH. Fur- 
thermore, although CSF or hCG alone had no effect on 
TNF production, the combination of the two increased 
TNF production significantly. These data document 
for the first time a role of gonadotropins and CSF in 
the regulation of TNF by the human preovulatory 
follicular GC. The function of TNF production by GC 
is unknown. However, since we have also found [3] 
that prior to ovulation TNF increases prostaglandin 
production by both bovine granulosa and theta cells, it 
is likely that TNF plays a role in the induction of the 
preovulatory increase of PG synthesis by GC. This is 
supported by the data showing that the bovine 
follicular fluid concentrations of TNF increased from 
mid-cycle to the periovulatory period. On the other 
hand, the significance of the effect of TNF in increas- 
ing granulosa progesterone production is not clear. 
Although this effect was statistically significant, it may 
well have been due to the increased prostanoid syn- 
thesis which by itself can increase progesterone produc- 
tion by the GC. 
The effect of TNF on PGF-2cu was biphasic. This 
could explain why FSH, which increased TNF produc- 
tion, paradoxically decreased PGF-ti production. 
Alternatively, since it has already been reported [l] that 
prostanoids have a negative feedback on TNF produc- 
tion by macrophages, it is possible that part of the ef- 
fect of FSH in increasing TNF production is the result 
of its suppression of PGF-2cu production. 
The combined effects of hCG and CSF on TNF pro- 
duction are intriguing but lack an obvious explanation. 
It is possible to speculate that hCG may act by inducing 
CSF receptors and the CSF is responsible for the TNF 
increase. Support for this concept emerges from the 
work of Pollard et al. [lo] who have shown an increase 
in CSF secretion by rat endometrial tissue at the time 
of ovulation. 
The field of growth factors and cytokines and their 
effects on reproduction is a rapidly growing new area 
of investigation. It appears that there is a complex in- 
terplay between the growth factors such as CSF, the 
cytokines and the gonadotropins [ 11,121. In addition, 
the present work shows that cytokines such as TNF-a 
can act as an autocrine hormone in that it is produced 
by its target organ, the follicular granulosa. 
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